A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

NCT02944955 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
52
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

BioLite, Inc.